Shu‐Fang Hsu Schmitz

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

Daniel Betticher, Shu‐Fang Hsu Schmitz, Martin Tötsch et al. · Journal of Clinical Oncology · 2003 · 455 citations

Medicine, Oncology, Pharmacology +17

Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98

Giovanni Martinelli, Shu‐Fang Hsu Schmitz, Urs Utiger et al. · Journal of Clinical Oncology · 2010 · 242 citations · Full text

Medicine, Immunology, Oncology +13

Effect of Single-Agent Rituximab Given at the Standard Schedule or As Prolonged Treatment in Patients With Mantle Cell Lymphoma: A Study of the Swiss Group for Clinical Cancer Research (SAKK)

Michele Ghielmini, Shu‐Fang Hsu Schmitz, Sergio Cogliatti et al. · Journal of Clinical Oncology · 2004 · 197 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Potential Influence of the Anesthetic Technique Used during Open Radical Prostatectomy on Prostate Cancer-related Outcome

Patrick Y. Wuethrich, Shu‐Fang Hsu Schmitz, Thomas M. Kessler et al. · Anesthesiology · 2010 · 161 citations · Full text

Medicine, Anesthesiology, Surgery +15

Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials

Liat Vidal, Anat Gafter‐Gvili, Gilles Salles et al. · JNCI Journal of the National Cancer Institute · 2011 · 130 citations · Full text

Medicine, Oncology, Pharmacotherapy +13